The Future of Therapy is Now: Harnessing AI to Optimize Care, Compliance, and Connection

November 20, 2025 1:00 PM

When many people hear the term artificial intelligence, their guard goes up, questions are raised about confidentiality, integrity, and a diminished human workforce; and understandably so. The rapid growth of generative AI has sparked as much anxiety as excitement in many workforce sectors and healthcare is no exception. However, compassion, critical thinking, and human connection can never be replaced by code.Yet, as Melinda Butler Henderson,...

Read more

FriskaAi Launches Direct-to-Consumer AI Health Companion in Michigan to Empower Individuals to Take Control of Chronic Conditions

November 20, 2025 1:00 PM

FriskaAi, an innovative healthcare platform and accompanying care management app that uses advanced AI and mobile technology to help individuals manage their health in partnership with their physicians, today announced its first-ever expansion beyond clinical settings with the launch of FriskaAi Chronic Care Management (CCM), a new version designed specifically for consumers.FriskaAi CCM blends technology with personalized human guidance to help...

Read more

Nomination Committee Appointed for IRLAB's Annual General Meeting 2026

November 20, 2025 11:00 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announces that the nomination committee ahead of the annual general meeting (AGM) 2026 has been appointed.According to the instruction for appointment of the nomination committee in IRLAB Therapeutics AB, resolved at the annual general meeting on May 22, 2024, the nomination committee shall, besides the Chair of the...

Read more

Signature Clinic Unveils new CO2 Laser Technology

November 20, 2025 10:50 AM

Signature Clinic, one of the UK's leading providers of cosmetic surgery, has unveiled a major investment in its aftercare treatment programme with the launch of its new CO₂ laser technology treatment. The Repair and Repair & Skin Renew programme will be introduced as the clinic celebrates its move to a newly refurbished, purpose-built Glasgow headquarters at 49 Crow Road, Partick, G11 7SH.The new services mark a significant evolution in...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Announces CEO Insider Purchase of 50 Million Shares of MDCE Common Stock

November 20, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) (the "Company") today announced that its Chief Executive Officer, Marshall Perkins, purchased 50,000,000 shares of MDCE common stock on the open market at an average purchase price of $0.0003 per share on November 19, 2025. The shares were purchased using personal funds and reflect a personal investment by Mr. Perkins. No new shares were issued by the Company in connection with this transaction,...

Read more

High-Demand 2026-2027 Hospital Board Playbook for Health IT Funding Decisions, Now in Use at 300+ U.S. Hospitals - Complimentary

November 20, 2025 9:15 AM

Black Book Research today announced the industry-wide availability of its 2026-2027 Boardroom Playbook for Hospital Health IT Approvals, a complimentary, 129-page resource manual developed independently and without vendor funding, sponsorship, or endorsement. Created specifically for hospital and health system boards, the manual is designed to help trustees make clearer, more informed and vendor-neutral decisions on health IT (HIT)...

Read more

TeleTracking Launches First AI-Powered Patient Throughput Solution, Decision IQ(R)

November 20, 2025 9:05 AM

TeleTracking Technologies, the market leader in healthcare operations platforms for hospitals and health systems, today announced the launch of Decision IQ, the first AI-driven solution designed to manage patient flow at scale, during its annual TeleSummit customer conference in Nashville. The solution is already in place at University of Louisville Health (UofL Health), where leaders are using it to address capacity constraints and improve...

Read more

Who is the best Rhinoplasty Surgeon in Seattle?

November 20, 2025 9:00 AM

In Seattle's growing field of facial plastic surgery, Dr. Javad Sajan of Allure Esthetic contributes to the evolution of rhinoplasty through a combination of structural preservation, ultrasonic precision, and individualized surgical planning. His approach integrates aesthetic refinement with functional correction, an area of continued interest in contemporary nasal surgery.Individualized Planning in RhinoplastyEach rhinoplasty procedure in Dr....

Read more

Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation

November 20, 2025 9:00 AM

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing and supplying nucleic acid delivery technology for partners in biotech and pharma, today announced that its associate company Altamira Medica ("Medica") obtained certification of its Bentrio® nasal spray under the European Union's Medical Device Regulation (MDR). Bentrio is a drug-free, preservative-free nasal spray for protection against...

Read more

In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for Ongoing Placebo-Controlled Clinical Trial

November 20, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that, in support of a possible expedited approval pathway for crofelemer for treatment of intestinal failure in patients with the ultrarare genetic disorder microvillus inclusion disease (MVID), the company has submitted an amended protocol to the U.S. Food and Drug Administration (FDA) for the company's ongoing placebo-controlled clinical trial...

Read more

CenExel Hosts Comprehensive Good Clinical Practice (GCP) Training to Strengthen Clinical Excellence Across Network

November 20, 2025 9:00 AM

CenExel, a leading network of clinical research sites, is hosting a two-day Good Clinical Practice (GCP) training initiative beginning today, November 20, 2025, at the Sheraton Grand Nashville. Nearly 80 attendees, including Principal Investigators, sub-Investigators, regulatory and quality professionals, and clinical operations leaders, have gathered to enhance their understanding of the core regulatory and ethical standards that underpin every...

Read more

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

November 20, 2025 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced successful submission and acceptance of the end-of-phase 1 meeting package to FDA and that the company is on track to hold the meeting later this year. The primary purpose of this meeting is to establish agency feedback and input into the clinical development and...

Read more

VSee Health Names Dr. Milton Chen as Chairman to Drive AI Infrastructure Growth

November 20, 2025 8:55 AM

VSee Health, Inc. (Nasdaq:VSEE), today announced the appointment of Dr. Milton Chen as Chairman of the Board.  Dr. Chen, the cofounder and CEO of VSee wrote the first version of the VSee software as a PhD student at Stanford University. Dr. Chen has defined VSee's strategy of no-code, low-code AI infrastructure.There are thousands of AI healthcare companies and open source and open weight models. For these AI modules to be deployed in hospitals,...

Read more

Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach

November 20, 2025 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics designed to minimize abuse and overdose risk, today announced that the Food and Drug Administration (FDA or Agency) provided Written Responses to a meeting request.Ensysce had requested guidance on its approach to the manufacture of PF614, wanting to understand the...

Read more

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

November 20, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced it has closed a five-year term loan facility for up to $1.5 billion of capital from Ares Management Credit Funds (Ares), a leading global alternative investment manager, to increase flexibility.The non-dilutive debt financing consists of three tranches over five years, including:A $600 million initial term loan funded at closingA $400 million delayed draw term loan facility (DDTL), available in...

Read more

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

November 20, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced program and financial updates at its Analyst Day event. The updates include mRNA pipeline progress and a three-year plan for strategic growth."Over the next three years, we expect to build a large seasonal vaccine franchise for at-risk populations and invest the cash generated into oncology and rare disease therapeutics," said Stéphane Bancel, CEO of Moderna. "We plan to deliver up to 10 percent...

Read more

TriageLogic's MedMessage Automate Saves 400+ Staff Minutes per Week

November 20, 2025 7:00 AM

Many healthcare administrators are searching for ways to improve front desk efficiency without compromising patient care. TriageLogic's MedMessage Automate offers a new solution by automating the intake and routing of patient messages, reducing administrative burdens and preventing delays in communication between nonclinical operators, patients, and care teams.Traditional message intake often depends on front desk staff to manually record and...

Read more

ESSE Care Welcomes Dr. Amanda Chu, Expanding Complex Minimally Invasive Surgery Offerings and Endometriosis Specialty Care 

November 20, 2025 7:00 AM

ESSE Care and Wellness, a leading boutique surgical endometriosis and reproductive health practice, is proud to announce the addition of Dr. Amanda Chu, a board-certified OB/GYN and fellowship-trained minimally invasive gynecologic surgeon, to its Manhattan care team. Dr. Chu's arrival enhances ESSE's mission to provide advanced, integrative care for patients navigating complex, often misunderstood conditions such as endometriosis, adenomyosis,...

Read more

Dr. Angela Fisher Launches First Neurodivergent-Affirming Institute Blending Medicine, Art & Empowerment

November 20, 2025 7:00 AM

Psychologist, author, and neurodivergent visionary Angela Fisher, PhD has announced the launch of the Neurodivergent Empowerment Institute (NEI)-a first-of-its-kind integrative wellness center and gallery space located in the heart of St. Petersburg's Warehouse Arts District.A nationally recognized pioneer in psychedelic-assisted therapy, trauma recovery, and neurodivergent advocacy, Dr. Fisher has spent two decades developing the...

Read more

Wellgistics Health Reports Third Quarter 2025 Financial Results and Provides Business Update

November 20, 2025 6:00 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of serialization of healthcare technology infrastructure into the individual patient fulfillment of prescription drug through pharmacies ‘From Manufacturer To Patient', today reported financial results for the period ended September 30, 2025 on Form 10-Q on November 19, 2025[1] and provided a business update from the CEO."The last 6 weeks...

Read more